SNP and gene associations use P < 10⁻¹⁰. Change threshold · Counts cover features with indexed GWAS data; — means unavailable.

GeneAssociated metabolitesResearch resources

GENE DETAIL · Glycine max

Glyma.16G139100

Description hypothetical protein

Gene interval Chr16:29632332–29634248 (-), Wm82.a2.v1 · 1-based inclusive

Arabidopsis ortholog NA

Genome context

Explore gene–feature relationships using Overlap or Within ±5 kb. Scope definitions

Explore research resources ↓
Associated metabolite features451Overlap
Maximum supporting SNP records1
Features with ≥2 supporting SNP records0

Supporting SNP records satisfy P < 10⁻¹⁰ and the selected positional scope. Counts cover the 30345 features with indexed GWAS data.

Additional descriptive statistic

Mean supporting SNP records per associated feature: 1.

Research resources

Follow this gene identifier to compare annotations, examine protein function and find supporting literature.

These links search the displayed identifier. Check the organism, genome assembly and evidence in the destination record.

Compare gene models, expression and reported orthologs

SoyBase gene-name translator ↗SoyBase expression resources ↗Legume Information System ↗

Use expression and ortholog evidence to develop a testable hypothesis. The linked resources do not establish the function of this soybean gene in the measured samples.

Associated metabolites

Browse associated features and open their GWAS evidence or compound candidates.

451 matching features · page 26 of 46

Metabolite IDCandidate annotationDeionized mass (Da)Supporting SNP recordsMinimum P
P28486 Tasumatrol E 648.2753 12.23e-13
P28585 5,7,2'-Trihydroxy-6-methoxyflavone 300.0624 18.886e-14
P28607 Fusaperazine A 312.0602 19.33e-18
P28725 Heme O 838.3641 11.102e-12
P28957 No candidate annotation 882.3863 12.479e-11
P29119 Validamycin E 659.2616 14.414e-12
P29198 Lipoyl-AMP 535.0994 13.96e-11
P29314 No candidate annotation 252.1318 12.435e-11
P29420 Sordarin-3-carboxylic acid 508.2654 13.013e-12
P29543 Aristoloterpenate II 527.1907 11.494e-12